Home > Compound List > Product Information
CPTH2_Molecular_structure_CAS_357649-93-5)
Click picture or here to close

CPTH2

Catalog No. C9873 Name Sigma Aldrich
CAS Number 357649-93-5 Website http://www.sigmaaldrich.com
M. F. C14H14ClN3S Telephone 1-800-521-8956
M. W. 291.79906 Fax
Purity ≥98% (HPLC) Email
Storage Chembase ID: 154037

SYNONYMS

IUPAC name
4-(4-chlorophenyl)-2-(2-cyclopentylidenehydrazin-1-yl)-1,3-thiazole
IUPAC Traditional name
4-(4-chlorophenyl)-2-(2-cyclopentylidenehydrazin-1-yl)-1,3-thiazole
Synonyms
Cyclopentylidene-[4-(4-chlorophenyl)thiazol-2-yl)hydrazone

DATABASE IDS

MDL Number MFCD02307488
CAS Number 357649-93-5

PROPERTIES

Empirical Formula (Hill Notation) C14H14ClN3S
Purity ≥98% (HPLC)
Apperance white to beige powder
Solubility DMSO: >10 mg/mL
MSDS Link Download
Storage Temperature 2-8°C
German water hazard class nwg

DETAILS

Description (English)
Biochem/physiol Actions
CPTH2 is a histone acetyltransferase (HAT) inhibitor modulating the Gcn5 network. Histone Acetyltransferase (HAT) inhibitor modulating Gcn5 network. Histone acetyltransferases (HATs) act as transcriptional coactivators. Histone acetylation plays an important role in regulating the chromatin structure and is tightly regulated by two classes of enzyme, histone acetyltransferases (HAT) and histone deacetylases (HDAC). Deregulated HAT and HDAC activity plays a role in the development of a range of cancers. Consequently, inhibitors of these enzymes have potential as anticancer agents.
Description (简体中文)
Biochem/physiol Actions
CPTH2 is a histone acetyltransferase (HAT) inhibitor modulating the Gcn5 network. Histone Acetyltransferase (HAT) inhibitor modulating Gcn5 network. Histone acetyltransferases (HATs) act as transcriptional coactivators. Histone acetylation plays an important role in regulating the chromatin structure and is tightly regulated by two classes of enzyme, histone acetyltransferases (HAT) and histone deacetylases (HDAC). Deregulated HAT and HDAC activity plays a role in the development of a range of cancers. Consequently, inhibitors of these enzymes have potential as anticancer agents.

REFERENCES